FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000671792> ?p ?o ?g. }

• W2000671792 endingPage "1006" @default.
• W2000671792 startingPage "1005" @default.
• W2000671792 abstract "Juvenile myoclonic epilepsy (JME) is one of the most frequently diagnosed of the idiopathic generalised epilepsy syndromes, but long term outcome data still remain sparse.A retrospective audit was undertaken in 186 patients (male: n = 78; female: n = 108) diagnosed with JME at the Epilepsy Unit at the Western Infirmary in Glasgow, Scotland between July 1981 and July 2012. Median age at treatment start was 16 years (range 13–44), with median follow-up of 14 years (range 2–32).Overall, 171 patients (92%) achieved remission with antiepileptic drug (AED) treatment (median 9.5 years; range 1–31). After discontinuing treatment in 28 patients, only 11 remained seizure-free off medication. Fifteen patients (8%) continued to have seizures despite having tried up to 8 AED regimens: (5 male, 10 female), 7 of whom had psychiatric comorbidities. AEDs most commonly prescribed included sodium valproate (VPA; n = 142), lamotrigine (LTG; n = 66) and levetiracetam (LEV; n = 22). More male patients than female attained remission with their first or second AED schedule (88% versus 56%). More male patients (44%) received VPA than female (31%) overall. Fewer male patients than female received LTG (26% versus 74%) and LEV (22% versus 78%). Of the monotherapies, remission was achieved using VPA (n = 74; 52%), LTG (n = 21; 32%) and LEV (n = 12, 55%). A total of 76 (25%) of AED schedules resulted in intolerable side-effects, including 29 with VPA, 12 with LTG and 4 with LEV.Overall, JME showed a high rate of seizure freedom with AED treatment. VPA appeared to be the most effective AED. Women tended to have a worse outcome than men, since they were increasingly less likely to receive VPA. Patients with psychiatric comorbidities also had a poorer prognosis." @default.
• W2000671792 created "2016-06-24" @default.
• W2000671792 creator A5020448510 @default.
• W2000671792 creator A5041942422 @default.
• W2000671792 creator A5062073716 @default.
• W2000671792 creator A5082543715 @default.
• W2000671792 date "2008-12-01" @default.
• W2000671792 modified "2023-09-29" @default.
• W2000671792 title "Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy" @default.
• W2000671792 cites W1994505439 @default.
• W2000671792 cites W1998027193 @default.
• W2000671792 cites W2079741027 @default.
• W2000671792 cites W2138769545 @default.
• W2000671792 cites W2142085398 @default.
• W2000671792 cites W2411079296 @default.
• W2000671792 doi "https://doi.org/10.1016/j.nmd.2008.09.002" @default.
• W2000671792 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18952428" @default.
• W2000671792 hasPublicationYear "2008" @default.
• W2000671792 type Work @default.
• W2000671792 sameAs 2000671792 @default.
• W2000671792 citedByCount "1" @default.
• W2000671792 crossrefType "journal-article" @default.
• W2000671792 hasAuthorship W2000671792A5020448510 @default.
• W2000671792 hasAuthorship W2000671792A5041942422 @default.
• W2000671792 hasAuthorship W2000671792A5062073716 @default.
• W2000671792 hasAuthorship W2000671792A5082543715 @default.
• W2000671792 hasConcept C118552586 @default.
• W2000671792 hasConcept C126322002 @default.
• W2000671792 hasConcept C187212893 @default.
• W2000671792 hasConcept C2777332695 @default.
• W2000671792 hasConcept C2778186239 @default.
• W2000671792 hasConcept C2778802184 @default.
• W2000671792 hasConcept C2779814861 @default.
• W2000671792 hasConcept C42219234 @default.
• W2000671792 hasConcept C71924100 @default.
• W2000671792 hasConceptScore W2000671792C118552586 @default.
• W2000671792 hasConceptScore W2000671792C126322002 @default.
• W2000671792 hasConceptScore W2000671792C187212893 @default.
• W2000671792 hasConceptScore W2000671792C2777332695 @default.
• W2000671792 hasConceptScore W2000671792C2778186239 @default.
• W2000671792 hasConceptScore W2000671792C2778802184 @default.
• W2000671792 hasConceptScore W2000671792C2779814861 @default.
• W2000671792 hasConceptScore W2000671792C42219234 @default.
• W2000671792 hasConceptScore W2000671792C71924100 @default.
• W2000671792 hasIssue "12" @default.
• W2000671792 hasLocation W20006717921 @default.
• W2000671792 hasLocation W20006717922 @default.
• W2000671792 hasOpenAccess W2000671792 @default.
• W2000671792 hasPrimaryLocation W20006717921 @default.
• W2000671792 hasRelatedWork W1565067236 @default.
• W2000671792 hasRelatedWork W1658899326 @default.
• W2000671792 hasRelatedWork W2004774594 @default.
• W2000671792 hasRelatedWork W2084611794 @default.
• W2000671792 hasRelatedWork W2158681127 @default.
• W2000671792 hasRelatedWork W2415298006 @default.
• W2000671792 hasRelatedWork W2947834350 @default.
• W2000671792 hasRelatedWork W2962756505 @default.
• W2000671792 hasRelatedWork W3011785407 @default.
• W2000671792 hasRelatedWork W4300072071 @default.
• W2000671792 hasVolume "18" @default.
• W2000671792 isParatext "false" @default.
• W2000671792 isRetracted "false" @default.
• W2000671792 magId "2000671792" @default.
• W2000671792 workType "article" @default.